Nightingale Research Logo
Placeholder

Nightingale

Research

Trials

Now

Recruiting

  • EASI-HF
    Recruiting

    EASI-HF

    Frankston VIC

    Effect of Vicadrostat and Empagliflozin in patients with HF and EF>40%.

    • Screening visit,
    • Take one tablet daily
    Ream more
  • Bax Duo Pacific
    Recruiting

    Bax Duo Pacific

    Adelaide SA

    Assess Baxdrostat in combination with Dapagliflozin on renal outcomes and CV mortality in participants with CKD and high blood pressure.

    • Screening visit,
    • Take one tablet daily

    Ream more
  • GPIX
    Recruiting

    GPIX

    Adelaide SA

    Effect of Tirzapetide on Adolescents with Obesity and 2 CV risk factors.

    • Two-part screening visit
    • Weekly self-administered injections (similar to Epipen)
    Ream more

Upcoming Trials

  • GZPW Attain Outcomes
    Upcoming

    Adelaide SA

    Effect of Orforglipron on patients with established CVD and/or CKD.

    Read more
  • Synergy MALO
    Upcoming

    Adelaide SA

    Effect of Tirzapetide vs Retatrutide or Placebo on participants with fatty liver disease with obesity.

    Read more
  • ZENITH
    Upcoming

    Adelaide SA

    Effect of Zilebesiran in addition to Standard of Care in adults with uncontrolled hypertension and CVD or at risk of CVD.

    Read more
  • EASI-ProTKT
    Upcoming

    Adelaide SA

    Effect of Vicadrostat and Empagliflozin in patients with HF and EF>40%

    Read more

Ongoing Trials

(Enrolment Closed)
  • GZBJ Triumph 2
    Ongoing

    Adelaide SA

    Effect of Retatrutide on participants without type 2 diabetes who have obesity and OSA.

    Read more
  • GZBJ Triumph 3
    Ongoing

    Adelaide SA

    Effect of Retatrutide on participants with or without type 2 diabetes who have obesity.

    Read more
  • GZBO
    Ongoing

    Adelaide SA

    Effect of Retatrutide on participants with CVD and/or CKD.

    Read more
  • GZBJ Triumph 1
    Ongoing

    Adelaide SA

    Effect of Retatrutide on participants without type 2 diabetes who have obesity and knee OA.

    Read more

Completed Trials

  • Vesalius
    Completed

    Adelaide SA | Goolwa SA

    Effect of Evolocumab on CV events in patients with CV risk but no prior MI or CVA.

    Read more
  • GPGN Surpass
    Completed

    Adelaide SA | Goolwa SA

    Effect of Tirzapetide vs Dulaglutide on CV events in patients with Type 2 Diabetes.

    Read more